The 23rd“Takamatsu”International Symposium for PD & MD in TOKYO第23回高松国際パーキンソン病シンポジウムin Tokyo


2024年3月16日(土)・17日(日)

プログラムProgram

Theme: Medical care of Movement Disorders for sustainable development

1st Day:16 Mar 2024(Saturday)

●10:00-10:10

Opening remarks
Nobutaka Hattori, Mitsutoshi Yamamoto

●10:10-11:40

Symposium 1 Frontiers in Diagnosis and Treatment of Movement Disorders
Chair:Ryosuke Takahashi, Hirohisa Watanabe

  • 1.New evidence of treatment for PD
    Speaker:Eduardo Tolosa
  • 2.Biological subtypes of PD
    Speaker:Francisco Cardoso
  • 3.The Role of Neuro-Imaging in Diagnosing Parkinsonian Disorders
    Speaker:Werner Poewe

●11:40-11:50

Short Break

●11:50-12:50

Symposium 2 Is the Brain-First and Body-First Progression Hypothesis correct in Parkinson's Disease?

Kyowa Kirin Co., Ltd.

Chair:Tatsushi Toda, Kazushi Takahashi

  • 1.Pathological Progression in PD from the viewpoint of pathology
    Speaker:Renpei Sengoku
  • 2.Pathological progression in PD from the viewpoint of neuroimaging
    Speaker:Tomoko Totsune

●12:50-13:50

Lunch Break

●13:50-14:50

Premium seminar Novel findings in Parkinson's disease
Chair:Genjiro Hirose, Mitsutoshi Yamamoto

  • 1.Biomarkers in PD
    Speaker:Louis Tan
  • 2.GWAS in PD
    Speaker:EK Tan

●14:50-15:50

Symposium 3 Development of new treatment for Parkinson's disease

ONO PHARMACEUTICAL CO., LTD.

Chair:Atsushi Takeda,  Yoshio Tsuboi

  • 1.PD drug development using iPS cells
    Speaker:Haruhisa Inoue
  • 2.Gene-based PD drug development
    Speaker:Hiroyuki Ishiura

●15:50-16:00

Coffee Break

●16:00-17:00

Symposium 4 Parkinson's disease treatment using patients data

Takeda Pharmaceutical Co., Ltd.

Chair:Kazunori Ito, Masahiko Tomiyama

  • 1.Biomarker analysis in prodromal cohort of Lewy body disease
    Speaker:Masahisa Katsuno
  • 2.Movement disorder's treatment from the perspective of community
    Speaker:Tetsuya Maeda

●17:00-18:00

Evening Seminar  ACP in Movement Disorders

Eisai Co., Ltd.

Chair:Tadashi Ichikawa, Shinji Saiki

  • 1.Parkinson's disease treatment from the viewpoint of L-dopa blood levels
    Speaker:Noriko Nishikawa
  • 2.ACP with digital devices
    Speaker:Genko Oyama

●18:00-18:10

Closing Remark
Nobutaka Hattori

●18:30

懇親会

2nd Day:17 Mar 2023(Sunday) Japanese session

●10:00- 10:50

パーキンソン病の在宅医療

大塚製薬株式会社

Chair:宇川 義一 Speaker:織茂 智之

●10:50-11:40

パーキンソン病の脳内ネットワーク

住友ファーマ株式会社

Chair:花島 律子  Speaker:坪井 崇

●11:40-12:30

デバイス治療の未来

アッヴィ合同会社

Chair:大熊 泰之 Speaker:下 泰司